Have questions? Visit https://www.reddit.com/r/SNPedia

rs1800595

From SNPedia

Orientationminus
Stabilizedminus
Geno Mag Summary
(A;A) 0 common in clinvar
(T;T) 0 Normal
Make rs1800595(A;G)
Make rs1800595(G;G)
ReferenceGRCh38 38.1/141
Chromosome1
Position169541110
GeneF5
is asnp
is mentioned by
dbSNPrs1800595
dbSNP (classic)rs1800595
ClinGenrs1800595
ebirs1800595
HLIrs1800595
Exacrs1800595
Gnomadrs1800595
Varsomers1800595
LitVarrs1800595
Maprs1800595
PheGenIrs1800595
Biobankrs1800595
1000 genomesrs1800595
hgdprs1800595
ensemblrs1800595
geneviewrs1800595
scholarrs1800595
googlers1800595
pharmgkbrs1800595
gwascentralrs1800595
openSNPrs1800595
23andMers1800595
SNPshotrs1800595
SNPdbers1800595
MSV3drs1800595
GWAS Ctlgrs1800595
Max Magnitude0

This polymorphism is also known as Factor V HR2, H1299R, His1299Arg (due to the resulting change from Histidine to Arginine in the protein) and A4070G (due to the allele being G instead of A).

Research shows that is related to the more commonly known "Factor V Leiden" mutation rs6025 .

"Factor V Leiden is present in 5% to 7% of the general population and 20% to 40% of individuals with venous thrombosis. The factor V R2 polymorphism is associated with decreased levels of factor V and it significantly increases risk of venous thrombosis in individuals who are heterozygous for the factor V Leiden mutation. Coexistence of the R2 polymorphism rs1800595 with factor V Leiden rs6025 increases the risk for venous thrombosis approximately to a 16-fold increased risk. The average age of the first thrombotic event is six years younger in individuals who are heterozygous for both factor V Leiden and the R2 polymorphism than in those with factor V Leiden alone. The R2 polymorphism is common in the general population, with one copy (heterozygous) in 10% of individuals. Among patients with venous thrombosis, approximately 12% are heterozygous for the R2 polymorphism." labcorp

"Factor V HR2 Allele, DNA Mutation Analysis is useful in patients who are carriers of Factor V Mutation (Leiden). Coinheritance of Factor V Mutation (Leiden) is associated with a 3-4-fold increased risk of venous thrombosis compared to inheritance of Factor V Mutation (Leiden) alone." http://www.questdiagnostics.com/testcenter/TestDetail.action?ntc=17902

"Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (Factor V Leiden) and His1299Arg substitutions in Factor V." http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2141.1997.3993213.x/pdf

"Coinheritance of the HR2 Haplotype in the Factor V Gene Confers an Increased Risk of Venous Thromboembolism to Carriers of Factor V R506Q (Factor V Leiden)." http://www.bloodjournal.org/content/94/9/3062?sso-checked=1

Table 1: R2 Haplotype SNPs. http://th.schattauer.de/de/contents/archive/issue/special/manuscript/8580/download.html


ClinVar
Risk rs1800595(G;G)
Alt rs1800595(G;G)
Reference Rs1800595(A;A)
Significance Probable-non-pathogenic
Disease not specified Thrombophilia due to activated protein C resistance
Variation info
Gene F5
CLNDBN not specified Thrombophilia due to activated protein C resistance
Reversed 1
HGVS NC_000001.10:g.169510348T>C
CLNSRC
CLNACC RCV000248447.1, RCV000332960.1,